Staff Scientist
Elarex
Jeremy Iwashkiw, PhD, is a Staff Scientist with Elarex, working on developing and characterizing stabilization technologies for therapeutic applications for proteomic, nucleic acid, and viral platforms. Prior to joining Elarex, he was the team lead of the Abcelex Technologies start up company creating and characterizing single domain antibodies for the treatment of diseases including bacterial and immuno-oncology. For his Postdoctoral Fellowship at Harvard Medical School with Dr. John Mekalanos, he focused on developing a platform for a novel method creating whole cell glycoconjugate vaccines. During his PhD in Microbiology and Biotechnology from the University of Alberta under the supervision of Dr. Mario Feldman, he studied the role of bacterial glycobiology in disease and exploiting glycosylation machinery for vaccine development.
Disclosure information not submitted.
Wednesday, October 19, 2022
10:00 AM – 10:30 AM ET